Skip to main content
. 2017 Oct 27;96(40):e8200. doi: 10.1097/MD.0000000000008200

Figure 2.

Figure 2

Mammography (A), breast ultrasound (B), and magnetic resonance imaging (C) do not show abnormalities in the breast. Positron emission tomography (D) shows abnormal increased FDG uptake in left axillary and left supraclavicular region. Positron emission tomography (E) does not show abnormal increased FDG uptake in the left neck and in the left supraclavicular and infraclavicular regions after neoadjuvant chemotherapy. FDG= flurodeoxyglucose.